April 10, 2020
Sanofi has kicked off a clinical trial for its rheumatoid arthritis (RA) drug Kevzara (sarilumab) for the treatment of severely ill patients with COVID-19 in Japan, the company’s local outpost told Jiho on April 9. Kevzara is being investigated for...read more